These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 37526463)
1. Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema. Soto B; Ahmed H; Pillai M; Park SS; Ploszaj M; Reece J; Taluru H; Bobrow D; Yu H; Lafortune P; Jundi B; Costanzo L; Dabo AJ; Foronjy RF; Mueller C; Ohlmeyer M; Geraghty P Am J Respir Cell Mol Biol; 2023 Nov; 69(5):533-544. PubMed ID: 37526463 [TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Activation of Protein Phosphatase 2A Counters Bleomycin-Induced Fibrosis in Mice. Pillai M; Lafortune P; Dabo A; Yu H; Park SS; Taluru H; Ahmed H; Bobrow D; Sattar Z; Jundi B; Reece J; Ortega RR; Soto B; Yewedalsew S; Foronjy R; Wyman A; Geraghty P; Ohlmeyer M ACS Pharmacol Transl Sci; 2023 Nov; 6(11):1659-1672. PubMed ID: 37974628 [TBL] [Abstract][Full Text] [Related]
3. Protein Phosphatase 2A Reduces Cigarette Smoke-induced Cathepsin S and Loss of Lung Function. Doherty DF; Nath S; Poon J; Foronjy RF; Ohlmeyer M; Dabo AJ; Salathe M; Birrell M; Belvisi M; Baumlin N; Kim MD; Weldon S; Taggart C; Geraghty P Am J Respir Crit Care Med; 2019 Jul; 200(1):51-62. PubMed ID: 30641028 [No Abstract] [Full Text] [Related]
4. Chronic Cigarette Smoke Exposure Subdues PP2A Activity by Enhancing Expression of the Oncogene CIP2A. Nath S; Ohlmeyer M; Salathe MA; Poon J; Baumlin N; Foronjy RF; Geraghty P Am J Respir Cell Mol Biol; 2018 Dec; 59(6):695-705. PubMed ID: 30011381 [TBL] [Abstract][Full Text] [Related]
14. SerpinB1 deficiency is not associated with increased susceptibility to pulmonary emphysema in mice. Cremona TP; Tschanz SA; von Garnier C; Benarafa C Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L981-9. PubMed ID: 24163143 [TBL] [Abstract][Full Text] [Related]
15. p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice. Marumo S; Hoshino Y; Kiyokawa H; Tanabe N; Sato A; Ogawa E; Muro S; Hirai T; Mishima M BMC Pulm Med; 2014 May; 14():79. PubMed ID: 24885161 [TBL] [Abstract][Full Text] [Related]
16. Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency. Devine AJ; Smith NJ; Joshi R; Fan Q; Borchers MT; Clair GC; Adkins JN; Varisco BM Chronic Obstr Pulm Dis; 2023 Oct; 10(4):380-391. PubMed ID: 37534975 [TBL] [Abstract][Full Text] [Related]
17. Editing out five Borel F; Sun H; Zieger M; Cox A; Cardozo B; Li W; Oliveira G; Davis A; Gruntman A; Flotte TR; Brodsky MH; Hoffman AM; Elmallah MK; Mueller C Proc Natl Acad Sci U S A; 2018 Mar; 115(11):2788-2793. PubMed ID: 29453277 [TBL] [Abstract][Full Text] [Related]
18. Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases. Yu H; Zaveri S; Sattar Z; Schaible M; Perez Gandara B; Uddin A; McGarvey LR; Ohlmeyer M; Geraghty P Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763671 [TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption. Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074 [TBL] [Abstract][Full Text] [Related]
20. Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells. Rahman MM; Rumzhum NN; Hansbro PM; Morris JC; Clark AR; Verrills NM; Ammit AJ Cell Signal; 2016 Apr; 28(4):325-34. PubMed ID: 26820662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]